Relación entre comorbilidad, anemia y respuesta a derivados eritropoyéticos en pacientes incluidos en programa de hemodiálisis periódicas
The relationship between comorbidity, anemia and response to erythropoiesis-stimulating agents in chronic hemodialysis
Leído
16051
Vecesse ha leído el artículo
2583
Total PDF
13468
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 47 | 6 | 53 |
| 2025 5 | 129 | 35 | 164 |
| 2025 4 | 127 | 24 | 151 |
| 2025 3 | 150 | 57 | 207 |
| 2025 2 | 101 | 29 | 130 |
| 2025 1 | 91 | 29 | 120 |
| 2024 12 | 83 | 26 | 109 |
| 2024 11 | 74 | 53 | 127 |
| 2024 10 | 85 | 41 | 126 |
| 2024 9 | 67 | 33 | 100 |
| 2024 8 | 90 | 63 | 153 |
| 2024 7 | 91 | 35 | 126 |
| 2024 6 | 111 | 45 | 156 |
| 2024 5 | 134 | 32 | 166 |
| 2024 4 | 151 | 35 | 186 |
| 2024 3 | 88 | 17 | 105 |
| 2024 2 | 67 | 43 | 110 |
| 2024 1 | 55 | 20 | 75 |
| 2023 12 | 78 | 23 | 101 |
| 2023 11 | 63 | 30 | 93 |
| 2023 10 | 66 | 32 | 98 |
| 2023 9 | 79 | 22 | 101 |
| 2023 8 | 67 | 25 | 92 |
| 2023 7 | 123 | 31 | 154 |
| 2023 6 | 96 | 29 | 125 |
| 2023 5 | 81 | 32 | 113 |
| 2023 4 | 52 | 17 | 69 |
| 2023 3 | 105 | 27 | 132 |
| 2023 2 | 72 | 14 | 86 |
| 2022 1 | 69 | 22 | 91 |
| 2022 12 | 65 | 25 | 90 |
| 2022 11 | 89 | 33 | 122 |
| 2022 10 | 101 | 38 | 139 |
| 2022 9 | 68 | 30 | 98 |
| 2022 8 | 85 | 40 | 125 |
| 2022 7 | 64 | 51 | 115 |
| 2022 6 | 65 | 36 | 101 |
| 2022 5 | 92 | 39 | 131 |
| 2022 4 | 90 | 46 | 136 |
| 2022 3 | 88 | 45 | 133 |
| 2022 2 | 96 | 36 | 132 |
| 2021 1 | 113 | 38 | 151 |
| 2021 12 | 87 | 37 | 124 |
| 2021 11 | 80 | 32 | 112 |
| 2021 10 | 84 | 37 | 121 |
| 2021 9 | 83 | 47 | 130 |
| 2021 8 | 97 | 36 | 133 |
| 2021 7 | 112 | 36 | 148 |
| 2021 6 | 129 | 19 | 148 |
| 2021 5 | 117 | 31 | 148 |
| 2021 4 | 116 | 59 | 175 |
| 2021 3 | 112 | 28 | 140 |
| 2021 2 | 96 | 10 | 106 |
| 2020 1 | 79 | 21 | 100 |
| 2020 12 | 58 | 13 | 71 |
| 2020 11 | 56 | 18 | 74 |
| 2020 10 | 85 | 18 | 103 |
| 2020 9 | 83 | 9 | 92 |
| 2020 8 | 75 | 11 | 86 |
| 2020 7 | 69 | 16 | 85 |
| 2020 6 | 73 | 34 | 107 |
| 2020 5 | 95 | 10 | 105 |
| 2020 4 | 77 | 18 | 95 |
| 2020 3 | 58 | 11 | 69 |
| 2020 2 | 81 | 21 | 102 |
| 2020 1 | 83 | 30 | 113 |
| 2019 12 | 78 | 21 | 99 |
| 2019 11 | 70 | 16 | 86 |
| 2019 10 | 45 | 18 | 63 |
| 2019 9 | 65 | 17 | 82 |
| 2019 8 | 44 | 21 | 65 |
| 2019 7 | 48 | 18 | 66 |
| 2019 6 | 45 | 17 | 62 |
| 2019 5 | 47 | 18 | 65 |
| 2019 4 | 105 | 27 | 132 |
| 2019 3 | 55 | 24 | 79 |
| 2019 2 | 37 | 22 | 59 |
| 2019 1 | 55 | 18 | 73 |
| 2018 12 | 72 | 36 | 108 |
| 2018 11 | 76 | 15 | 91 |
| 2018 10 | 82 | 9 | 91 |
| 2018 9 | 67 | 22 | 89 |
| 2018 8 | 55 | 21 | 76 |
| 2018 7 | 53 | 18 | 71 |
| 2018 6 | 66 | 20 | 86 |
| 2018 5 | 44 | 19 | 63 |
| 2018 4 | 66 | 11 | 77 |
| 2018 3 | 44 | 14 | 58 |
| 2018 2 | 54 | 5 | 59 |
| 2018 1 | 36 | 12 | 48 |
| 2017 12 | 51 | 7 | 58 |
| 2017 11 | 45 | 12 | 57 |
| 2017 10 | 52 | 7 | 59 |
| 2017 9 | 62 | 10 | 72 |
| 2017 8 | 77 | 24 | 101 |
| 2017 7 | 67 | 11 | 78 |
| 2017 6 | 68 | 8 | 76 |
| 2017 5 | 58 | 10 | 68 |
| 2017 4 | 55 | 7 | 62 |
| 2017 3 | 48 | 6 | 54 |
| 2017 2 | 49 | 4 | 53 |
| 2016 1 | 72 | 7 | 79 |
| 2016 12 | 71 | 12 | 83 |
| 2016 11 | 108 | 7 | 115 |
| 2016 10 | 107 | 8 | 115 |
| 2016 9 | 150 | 2 | 152 |
| 2016 8 | 192 | 7 | 199 |
| 2016 7 | 213 | 9 | 222 |
| 2016 6 | 120 | 0 | 120 |
| 2016 5 | 141 | 0 | 141 |
| 2016 4 | 101 | 0 | 101 |
| 2016 3 | 81 | 0 | 81 |
| 2016 2 | 116 | 0 | 116 |
| 2015 1 | 140 | 0 | 140 |
| 2015 12 | 137 | 0 | 137 |
| 2015 11 | 101 | 0 | 101 |
| 2015 10 | 98 | 0 | 98 |
| 2015 9 | 110 | 0 | 110 |
| 2015 8 | 82 | 0 | 82 |
| 2015 7 | 92 | 0 | 92 |
| 2015 6 | 53 | 0 | 53 |
| 2015 5 | 92 | 0 | 92 |
| 2015 4 | 16 | 0 | 16 |
| 2015 2 | 3241 | 0 | 3241 |
Mostrar todo
